Literature DB >> 17473844

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses.

Kate L Jeffrey1, Montserrat Camps, Christian Rommel, Charles R Mackay.   

Abstract

Dual-specificity phosphatases (DUSPs) are a subset of protein tyrosine phosphatases, many of which dephosphorylate threonine and tyrosine residues on mitogen-activated protein kinases (MAPKs), and hence are also referred to as MAPK phosphatases (MKPs). The regulated expression and activity of DUSP family members in different cells and tissues controls MAPK intensity and duration to determine the type of physiological response. For immune cells, DUSPs regulate responses in both positive and negative ways, and DUSP-deficient mice have been used to identify individual DUSPs as key regulators of immune responses. From a drug discovery perspective, DUSP family members are promising drug targets for manipulating MAPK-dependent immune responses in a cell-type and disease-context-dependent manner, to either boost or subdue immune responses in cancers, infectious diseases or inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17473844     DOI: 10.1038/nrd2289

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  200 in total

1.  Dusp5 negatively regulates IL-33-mediated eosinophil survival and function.

Authors:  Derek A Holmes; Jung-Hua Yeh; Donghong Yan; Min Xu; Andrew C Chan
Journal:  EMBO J       Date:  2014-11-14       Impact factor: 11.598

2.  Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro.

Authors:  Fen Wu; Hong Sun; Thomas Kluz; Hailey A Clancy; Kathrin Kiok; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-04       Impact factor: 4.219

3.  Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors.

Authors:  Oliver Dick; Hilmar Bading
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

4.  Keep the 'phospho' on MAPK, be happy.

Authors:  Schahram Akbarian; Roger J Davis
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

Review 5.  Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?

Authors:  Tetyana V Bagnyukova; Ilya G Serebriiskii; Yan Zhou; Elizabeth A Hopper-Borge; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Biol Ther       Date:  2010-11-01       Impact factor: 4.742

6.  Map kinase phosphatase 5 protects against sepsis-induced acute lung injury.

Authors:  Feng Qian; Jing Deng; Benjamin N Gantner; Richard A Flavell; Chen Dong; John W Christman; Richard D Ye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

7.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

8.  DUSP3 Genetic Deletion Confers M2-like Macrophage-Dependent Tolerance to Septic Shock.

Authors:  Pratibha Singh; Lien Dejager; Mathieu Amand; Emilie Theatre; Maud Vandereyken; Tinatin Zurashvili; Maneesh Singh; Matthias Mack; Steven Timmermans; Lucia Musumeci; Emmanuel Dejardin; Tomas Mustelin; Jo A Van Ginderachter; Michel Moutschen; Cécile Oury; Claude Libert; Souad Rahmouni
Journal:  J Immunol       Date:  2015-04-15       Impact factor: 5.422

9.  Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.

Authors:  Stephen Paul Armstrong; Christopher James Caunt; Craig Alexander McArdle
Journal:  Mol Endocrinol       Date:  2009-01-29

10.  Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.

Authors:  Stefan Avey; Subhasis Mohanty; Daniel G Chawla; Hailong Meng; Thilinie Bandaranayake; Ikuyo Ueda; Heidi J Zapata; Koonam Park; Tamara P Blevins; Sui Tsang; Robert B Belshe; Susan M Kaech; Albert C Shaw; Steven H Kleinstein
Journal:  J Immunol       Date:  2020-02-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.